Additive Effect on Survival of Raf Kinase Inhibitor Protein and Signal Transducer and Activator of Transcription 3 in High-Grade Glioma

作者：Maresch Judith; Birner Peter; Zakharinov Mikhail; Toumangelova Uzeir Kalina; Natchev Sevdalin; Guentchev Marin^*

来源：Cancer, 2011, 117(11): 2499-2504.

DOI：10.1002/cncr.25799

• glioblastoma
• high-grade glioma
• RKIP
• STAT3
• survival

BACKGROUND: Animal studies have shown cooperative contribution of the Ras/Raf/MAPK and PI3K/Akt/mTOR signaling pathways in glioblastoma formation. However, this joint action has not yet been confirmed in human studies. METHODS: The expression of Raf kinase inhibitory protein (RKIP) was examined in 159 patients with high-grade and low-grade gliomas and correlated with previously obtained data on the activation of signal transducer and activator of transcription 3 (STAT3), a downstream effector of the PI3K/Akt/mTOR signaling pathway. RESULTS: RKIP expression was associated with a longer overall survival in high-grade glioma cases without showing a direct or inverse correlation with tyrosine-705 phosphorylation of STAT3 (pSTAT3). Notably, RKIP-positive and pSTAT3 negative cases demarcate a patients group with exceptionally long survival, exceeding the prognostic impact of each single marker. CONCLUSIONS: The results of this study indicated that 1) RKIP expression correlates with tumor grade and is a marker for good prognosis in high-grade gliomas; 2) RKIP expression and lack of pSTAT3 have a cumulative prognostic impact; and 3) RKIP and pSTAT3 are likely to operate independently to influence survival. These findings represented the first human evidence of an additive effect of 2 distinct signaling pathways in high-grade glioma, suggesting that simultaneous inhibition of multiple pathways should be considered as a treatment strategy for these patients. Cancer 2011; 117: 2499-504.

• 出版日期2011-6-1